Last reviewed · How we verify
NCT03292770: MUCRET
Mucus Removal Before Embryo Transfer
NA trial testing Flushing Catheter in Infertility in 1,118 participants. Completed in 30 May 2018.
30 May 2018
Quick facts
| Lead sponsor | Fundacion Dexeus |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 1,118 |
| Start date | 20 October 2017 |
| Primary completion | 30 May 2018 |
| Estimated completion | 30 May 2018 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Flushing Catheter
Conditions studied
- Infertility — all drugs for Infertility →
- Embryo Transfer — all drugs for Embryo Transfer →
Sponsor
Fundacion Dexeus — full company profile →
Who can join
Under 40, female only, with Infertility or Embryo Transfer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Despite these revolutionary changes in the laboratory, little has changed with the process of embryo transfer (ET). A study to prospectively evaluate the role of cervical mucus removal prior to embryo transfer on pregnancy rates in ART will be undertaken.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03292770
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infertility
Currently open trials in the same condition.
- NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
- NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
- NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
- NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
- NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting
Other Fundacion Dexeus trials
Trials by the same sponsor.
- NCT06763926 — Intranasal Nafarelin For Triggering Oocyte Maturation · Phase 4 · not yet recruiting
- NCT05836974 — Performance Evaluation of the ex Utero Cord Blood Collection Technique: Procedure, Quality and Results · NA · completed
- NCT04259021 — The Voice Analysis as a Preoperative Prediction Method of a Difficult Airway · completed
- NCT04108039 — Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. · NA · completed
- NCT03760783 — The Effects of Microgravity on Human Sperm · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03292770 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundacion Dexeus
- Last refreshed: 31 May 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03292770.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing